PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.
Also known as: ABP-7
ABP-7 is a research peptide marketed as an analog within the alpha-MSH / melanocortin family, studied for its potential anti-inflammatory and tissue-protective signaling.
Sign in to rate this peptide.
ABP-7 is described as a melanocortin-pathway agonist that acts on melanocortin receptors (notably MC1R and MC3R) expressed on immune and tissue cells. Activation of these G-protein-coupled receptors raises intracellular cAMP and downregulates pro-inflammatory transcription factors such as NF-kB, reducing cytokine output. By biasing macrophages toward a resolving phenotype, melanocortin agonists in this class are studied for resolution of inflammation rather than simple suppression.